Chemours
515 hedge funds and large institutions have $3.54B invested in Chemours in 2022 Q2 according to their latest regulatory filings, with 80 funds opening new positions, 120 increasing their positions, 174 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
31% less repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 174
48% less call options, than puts
Call options by funds: $60.6M | Put options by funds: $116M
Holders
515
Holding in Top 10
7
Calls
$60.6M
Puts
$116M
Top Buyers
| 1 | +$56.1M | |
| 2 | +$31.9M | |
| 3 | +$21.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$17.7M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$17.4M |
Top Sellers
| 1 | -$128M | |
| 2 | -$46.2M | |
| 3 | -$30.7M | |
| 4 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$22.3M |
| 5 |
Millennium Management
New York
|
-$20.4M |